Trial Profile
Ensayo Clinico Fase II para evaluar la eficacia de la combinacion con sorafenib + dacarbacina (DTIC) en pacientes con melanoma metastasico (estadio IV) (estudio SORAFENIB-DTIC).
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 May 2011
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Dacarbazine
- Indications Malignant melanoma
- Focus Therapeutic Use
- 31 May 2011 New trial record